Novartis & Alcon's takeover
Upcoming SlideShare
Loading in...5
×
 

Novartis & Alcon's takeover

on

  • 1,273 views

Analysis of Novartis & Alcon's takeover in 2009

Analysis of Novartis & Alcon's takeover in 2009

Statistics

Views

Total Views
1,273
Views on SlideShare
1,269
Embed Views
4

Actions

Likes
0
Downloads
25
Comments
0

1 Embed 4

http://www.linkedin.com 4

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Novartis & Alcon's takeover Novartis & Alcon's takeover Presentation Transcript

  • Novartis & Alcon
    The takeover
    Jérémie LORRAIN & Kelly BLASCO
  • Introduction
    What is a Takeover?
    Friendly
    Hostile
  • Overview
    Presentation of the companies
    Reasons of the takeover
    Stock Market
    How does Novartis finance it?
  • Novartis
    Swiss pharmaceutical company
    Created in 1996
    2009 turnover: $ 44,3 billion
    Employees: 100 000
  • Alcon
    American pharmaceutical firm
    Founded in 1945 by R.Alexander & W.Coner
    2008 turnover: $ 6 293 billion
    Employees: 15 000
  • Reasons of the takeover
    28 billion dollars
    Strengthen innovation power & diversify its range of medication
    Together they cover more than 70% of the global vision care sector
    Benefice for the shareholders, employees and patients
  • Stock Market - Alcon
    19th February stock price : $ 159.08
    15th March stock price: $162.48
  • Stock Market - Novartis
    • 5thfebruary: Novartis’ shares were worth 57,75 dollars
    • Today: 58,35 dollars
  • How does Novartis finance it?
    $14 billion to be financed
    Strong cash flow
    Mix of bonds and loans
    Selling shares
  • Conclusion
    Future success ?